Transient decline in serum progesterone levels during prostaglandin F2alpha infusion in the midluteal phase of the normal human menstrual cycle.
D000328:Adult; D001800:Blood Specimen Collection; D003338:Corpus Luteum / Q000187:drug effects*; D003967:Diarrhea / Q000139:chemically induced; D004562:Electrocardiography; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007263:Infusions, Parenteral; D007986:Luteinizing Hormone / Q000097:blood; D008598:Menstruation / Q000187:drug effects*; D009325:Nausea / Q000139:chemically induced; D011374:Progesterone / Q000097:blood*; D011453:Prostaglandins / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D011863:Radioimmunoassay; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D011453:Prostaglandins; D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone